Cardiology
Home Cardiology
CV Risk Not Significantly Different for GLP-1 Receptor Agonists
Findings based on large study in real-world, head-to-head comparison of other drugs
Doctors Can Be Misled About FDA ‘Breakthrough’ Drug Designation
Many believe meds supported by stronger evidence than the law requires to achieve designation
USPSTF: Aspirin Recommended for Some Aged 50 to 69 Years
Benefits for primary prevention of CVD, CRC for certain adults aged 50 to 69 years
Progesterone Attenuates Drug-Induced QT Interval Lengthening
Findings in healthy females who received progesterone or placebo for seven days
VA Commission on Care: Eliminate VA Medical Centers
Eight veterans organizations denounce document in letter to Commission Chairwoman
Telomere Length Tied to Higher Myocardial Infarction Risk
Large multiethnic study shows linear relationship when telomere length is divided into tertiles
ACEI/ARBs Up AMI Outcomes Regardless of Renal Status
Treatment linked to improved long-term survival, regardless of underlying kidney function
Niacin-ER May Be Overlooked Cause of Thrombocytopenia
Researchers also note marked improvement in hemoglobin upon drug discontinuation in anemia
Sacubitril-Valsartan May Be Cost-Effective Option in HFrEF
More costly than enalapril but more effective over a lifetime in heart failure with reduced ejection fraction
New Dietary Guidelines for Americans Issued for 2015-2020
Guidelines include limit on added sugars and encourage daily coffee consumption
